| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |